10-K
Annual Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
28 line items · 2 periods
XBRL
| Item | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|
Current assets: | ||
Cash | 8,608,000 | 865,000 |
Other current assets | 783,000 | 0 |
Total current assets | 9,391,000 | 865,000 |
Long-term assets: | ||
Fixed assets, net | 16,000 | 0 |
Total long-term assets | 16,000 | 0 |
Total Assets | 9,407,000 | 865,000 |
Current liabilities: | ||
Accounts payable | 492,000 | 173,000 |
Accrued expenses | 285,000 | 48,000 |
Total current liabilities | 777,000 | 221,000 |
Long-term liabilities: | ||
Long term debt - convertible notes, net of unamortized debt discount | 1,002,000 | 0 |
The Notes - Convertible Debt | 1,002,000 | — |
Total long-term liabilities | 1,002,000 | 0 |
Total Liabilities | 1,779,000 | 221,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2024, no shares issued and outstanding, and 7,100,000 shares authorized as of March 31, 2023, no shares issued and outstanding | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2024, 18,846,094 shares issued and outstanding, and 25,000,000 shares authorized as of March 31, 2023, 12,336,571 shares issued and outstanding | 19,000 | 12,000 |
Additional paid-in capital | 46,578,000 | 24,175,000 |
Accumulated deficit | (38,969,000) | (23,543,000) |
Total Stockholders' Equity | 7,628,000 | 644,000 |
Preferred Stock | 0 | 0 |
Common Stock | 19,000 | 12,000 |
Additional Paid-in Capital | 46,578,000 | 24,175,000 |
Retained Earnings | (38,969,000) | (23,543,000) |
Total Liabilities and Stockholders' Equity | 9,407,000 | 865,000 |